Insulin Assay Buffer Composition for Nonspecific Reaction Suppression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Sandwich latex turbidimetric immunoassays for human insulin face issues with nonspecific reactions, particularly when compared to conventional chemiluminescent enzyme immunoassays, leading to deviations in measurement values.

Innovation Solution

Performing immunoreactions with anti-insulin antibody-immobilized particles in a buffer containing two or more amine compounds with pH buffering effects, such as HEPES, MES, and Tris, at concentrations between 100 mM to 1000 mM and pH 7.3 to 7.8 to suppress nonspecific reactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If sandwich LTIA is performed with conventional buffer, then the assay can be conducted, but nonspecific reaction occurs causing deviation from conventional method values

Engineering Contradiction:
Improvemeasurement accuracyVSAvoidnonsspecific reaction
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent changes the buffer composition parameters by incorporating two or more specific pH buffering agents (HEPES, MES, Tris) in specific concentrations (100-1000 mM total) and pH range (7.3-7.8), which suppresses nonspecific reaction and reduces deviation from conventional method values while maintaining the sandwich LTIA format

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite buffer system containing two or more different pH buffering agents working together, rather than a single buffering agent, to achieve both pH stability and suppression of nonsspecific reaction in the insulin assay

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces deviations in measurement values, effectively suppressing nonspecific reactions and improving the accuracy of human insulin latex agglutination immunoassays.

Implementation Method 1

human insulin latex agglutination immunoassay

Methodology Applied
Scientific EffectAgglutination: Flocculation

Implementation Method 2

performing an immunoreaction with anti-insulin antibody-immobilized particles in a buffer containing two or more amine compounds having a pH buffering effect

Methodology Applied
Scientific EffectpH buffering:

Data Source

PatentEP2980586B1Insulin assay method
Publication Date: 2017.08.16 SEKISUI MEDICAL CO LTD
  • EP2980586B1 patent drawingFigure 1

AI summary

Provided herein is a human insulin latex agglutination immunoassay and assay reagents with which nonspecific reaction in a blood sample assay can be suppressed. The assay performs an immunoreaction with anti-insulin antibody-immobilized particles in a buffer containing two or more amine compounds having a pH buffering effect.